Large B‐cell lymphoma with Hodgkin's features
- 27 June 2005
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 47 (1) , 101-110
Abstract
Aims : To describe the features of a series of nine cases of diffuse large B‐cell lymphoma (DLBCL) showing morphological and immunophenotypic features that are intermediate with Hodgkin's lymphoma (HL).Methods and results : Most cases (6/9) presented as mediastinal tumours affecting young males, while the other three cases arose in extramediastinal locations. Histopathologically, tumours showed diffuse large cell areas in a polymorphous background, with pleomorphic cytology and the common presence of Hodgkin's and Reed–Sternberg cells. Immunophenotypically, tumours shared features of DLBCL and classical HL, with expression of CD30, CD15 (6/9), and a full B‐cell profile including CD45RB, CD20, CD79a and OCT2. Epstein–Barr virus–latent membrane protein expression was found in 2/9 cases. The majority of tumours had immunohistochemical features consistent with activation of the NF‐κB pathway, including nuclear location of the c‐REL/p65 subunit, overexpression of phosphorylated IκBα, and overexpression of NF‐κB targets. Finally, 2/9 cases showed 3q27 (BCL6) rearrangement, and 1/9 had p53 gene mutations, both of which are rarely detected in classical HL.Conclusions : These findings suggest that DLBCLs with HL features constitute a distinctive subgroup of aggressive lymphomas whose neoplastic growth and peculiar characteristics could be facilitated by a particular microenvironment found in the mediastinum.Keywords
This publication has 26 references indexed in Scilit:
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2003
- The B-Cell Transcription Factors BSAP, Oct-2, and BOB.1 and the Pan–B-Cell Markers CD20, CD22, and CD79a Are Useful in the Differential Diagnosis of Classic Hodgkin LymphomaAmerican Journal of Clinical Pathology, 2003
- The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphomaBlood, 2003
- Cell cycle deregulation in B-cell lymphomasBlood, 2003
- MAL Expression in Lymphoid Cells: Further Evidence for MAL as a Distinct Molecular Marker of Primary Mediastinal Large B-Cell LymphomasLaboratory Investigation, 2002
- Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in LymphomasLaboratory Investigation, 2002
- TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virusInternational Journal of Cancer, 2001
- Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cellsBlood, 2001
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.Journal of Clinical Investigation, 1997